Fundamental Concepts in Clinical Pharmacology

作者: Daniel L. Gustafson , Erica L. Bradshaw-Pierce

DOI: 10.1007/978-1-4419-7358-0_2

关键词:

摘要: Clinical pharmacology is the study of drugs in healthy volunteers and patients defining relationships between dose, drug exposure, response populations. Drug dose refers to an amount administered via a particular route (e.g., intravenous, oral, subcutaneous). exposure function concentration body, usually levels blood/plasma/serum serve as surrogate, with respect time. Response measure effect can relate both advantageous (efficacy) untoward (toxic) reactions. The dose–response relationship for based on route, that defined by pharmacokinetics (ADME) (Fig. 2.1). Pharmacokinetics (PK) loosely what body does comprised absorption, distribution, metabolism, elimination profile. A key principal clinical studying how PK differs amongst Initial studies humans most are done healthy, volunteer populations results extrapolated refined patient

参考文章(17)
L Aarons, Population pharmacokinetics: theory and practice. British Journal of Clinical Pharmacology. ,vol. 32, pp. 669- 670 ,(1991) , 10.1111/J.1365-2125.1991.TB03971.X
Seymour Perry, Reduction of Toxicity in Cancer Chemotherapy Cancer Research. ,vol. 29, pp. 2319- 2325 ,(1969)
Thomas M. Ludden, Nonlinear pharmacokinetics: clinical Implications. Clinical Pharmacokinectics. ,vol. 20, pp. 429- 446 ,(1991) , 10.2165/00003088-199120060-00001
Sufi Mary Thomas, Jennifer Rubin Grandis, Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation. Cancer Treatment Reviews. ,vol. 30, pp. 255- 268 ,(2004) , 10.1016/J.CTRV.2003.10.003
Lewis B. Sheiner, Barr Rosenberg, Kenneth L. Melmon, Modelling of individual pharmacokinetics for computer-aided drug dosage Computers and Biomedical Research. ,vol. 5, pp. 441- 459 ,(1972) , 10.1016/0010-4809(72)90051-1
Erica L. Bradshaw-Pierce, S. Gail Eckhardt, Daniel L. Gustafson, A Physiologically Based Pharmacokinetic Model of Docetaxel Disposition: from Mouse to Man Clinical Cancer Research. ,vol. 13, pp. 2768- 2776 ,(2007) , 10.1158/1078-0432.CCR-06-2362
Lewis B. Sheiner, Barr Rosenberg, Vinay V. Marathe, Estimation of population characteristics of pharmacokinetic parameters from routine clinical data Journal of Pharmacokinetics and Biopharmaceutics. ,vol. 5, pp. 445- 479 ,(1977) , 10.1007/BF01061728
Fred F. Farris, Franklin G. King, Robert L. Dedrick, Charles L. Litterst, Physiological model for the pharmacokinetics of cis-dichlorodiammineplatinum (II) (DDP) in the tumored rat. Journal of Pharmacokinetics and Biopharmaceutics. ,vol. 13, pp. 13- 39 ,(1985) , 10.1007/BF01073654